fibronectin glomerulopathy
MeSH: C536826ORPHA: 840901 Treatment Available
Overview
Fibronectin glomerulopathy is a hereditary kidney disease characterized by proteinuria, type IV renal tubular acidosis, microscopic hematuria and hypertension that may lead to end-stage renal failure in the second to sixth decade of life
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Tacrolimus | Capsule, Tablet, IV solution | FDA Approved | 5 | 7d |
Clinical Presentation
Signs and symptoms associated with fibronectin glomerulopathy, sourced from HPO and Orphanet clinical annotations.
Renal insufficiencyProteinuriaNephrotic syndromeHypertensionCerebral hemorrhageAbnormal glomerular mesangium morphologyMicroscopic hematuriaHypoalbuminemiaPedal edemaGlomerulopathy
Classification & Codes
MeSH Code
C536826Orphanet Code
ORPHA:84090fibronectin glomerulopathy
| MeSH | C536826 |
| Orphanet | ORPHA:84090 |
| Treatments | 1 drug(s) |
| Symptoms on record | 10 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO